"We are very pleased with the FDA's recognition of choline as an essential nutrient with a Reference Daily Intake of 550mg," said Eric Smith, Vice President of Human Nutrition and Pharma. "This recognition validates the science that Balchem has supported over many years. We look forward to working with supplement and food manufacturers to leverage this greater visibility for choline to further improve the health and wellness of people around the world."Balchem, the global leader in choline, produces VitaCholine ®, a line of high-quality water-soluble choline salts that can be used to fortify a wide range of supplements and foods. VitaCholine ® offers relevant and important nutritional benefits by helping consumers around the globe attain proper levels of choline in the diet. About Balchem CorporationFounded in 1967, Balchem is a global wellness company that provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. Our Company consists of four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. Balchem employs over 800 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. Forward-Looking Statements Any statements in this press release about future expectations, plans and prospects for Balchem and other statements containing the words "believes," "anticipates," "plans," "expects," "will," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements reflect Balchem's expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem's expectations and risks and factors identified in Balchem's annual report on Form 10-K for the year ended December 31, 2015. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date, except as required by law.
For more information:Tom Druke(845) email@example.com